Immunosenescence and Vaccine Efficacy in Aging: Dynamic Interplay of Gut Microbiota and mTOR Signaling Pathways
Open Access
- 22 May 2026
- journal article
- review article
- Published by Wiley in Aging Cell
- Vol. 25 (6) , e70548
Abstract
Aging significantly impairs vaccine efficacy in older adults, driven by immunosenescence, inflammaging, and disruptions in the gut microbiota‐mTOR‐immune axis. This review synthesizes current evidence on how aging alters vaccine‐induced immune responses through the interplay of gut microbiota dysbiosis and dysregulated mTOR signaling. Age‐related microbial diversity declines and reduced short‐chain fatty acid (SCFA) production exacerbate inflammation, while heightened mTOR activity suppresses autophagy, promotes pro‐inflammatory states, and impairs T/B cell function, collectively diminishing antibody production and immune memory formation. We highlight the bidirectional interaction between SCFAs and mTOR, where SCFAs mitigate mTOR overactivation to enhance immune regulation, and mTOR dysregulation further aggravates microbial dysbiosis, forming a vicious cycle. Critically, this review systematically stratifies the evidence, distinguishing preclinical mechanistic insights from correlative human data. Animal and human studies suggest that targeting this axis—via mTOR inhibitors, probiotics, or dietary interventions—holds promise for improving vaccine responses in the elderly. We propose future research directions, including personalized vaccine strategies leveraging microbiota profiling and mTOR modulation, to address the challenges of infection in aging populations and advance precision medicine for healthy aging.Keywords
This publication has 128 references indexed in Scilit:
- Breaking Barriers; Phytoestrogens in the Fight Against Triple‐Negative Breast Cancer: A Comprehensive ReviewMedicinal Research Reviews, 2025
- The senotherapeutic potential of phytochemicals for age-related intestinal diseaseAgeing Research Reviews, 2024
- The metabolic and endocrine impact of diet-derived gut microbiota metabolites on ageing and longevityAgeing Research Reviews, 2024
- Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventionsMedcomm, 2024
- Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer ImmunotherapyAdvanced Materials, 2024
- Mammalian Target of Rapamycin Complex 1 Activation in Macrophages Contributes to Persistent Lung Inflammation following Respiratory Tract Viral InfectionThe American Journal of Pathology, 2023
- On the wake of metformin: Do anti-diabetic SGLT2 inhibitors exert anti-aging effects?Ageing Research Reviews, 2023
- Antifragility and antiinflammaging: Can they play a role for a healthy longevity?Ageing Research Reviews, 2022
- Metabolic modeling of single Th17 cells reveals regulators of autoimmunityCell, 2021
- Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic NicheCell, 2016